These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 36466841)

  • 1. Pathophysiological mechanisms of thrombosis in acute and long COVID-19.
    Jing H; Wu X; Xiang M; Liu L; Novakovic VA; Shi J
    Front Immunol; 2022; 13():992384. PubMed ID: 36466841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation.
    Wang C; Yu C; Jing H; Wu X; Novakovic VA; Xie R; Shi J
    Front Cell Infect Microbiol; 2022; 12():861703. PubMed ID: 35449732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases.
    Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting.
    Zhao L; Wu X; Si Y; Yao Z; Dong Z; Novakovic VA; Guo L; Tong D; Chen H; Bi Y; Kou J; Shi H; Tian Y; Hu S; Zhou J; Shi J
    J Neurosurg; 2017 Nov; 127(5):1041-1054. PubMed ID: 28009236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Microparticles in the Pathogenesis and Early Anticoagulation of Thrombosis in COVID-19 With Kidney Injury.
    Wang C; Yu C; Novakovic VA; Xie R; Shi J
    Front Cell Dev Biol; 2021; 9():784505. PubMed ID: 35118071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Central Role of Extracellular Vesicles in the Mechanisms of Thrombosis in COVID-19 Patients With Cancer and Therapeutic Strategies.
    Jing H; Zuo N; Novakovic VA; Shi J
    Front Cell Dev Biol; 2021; 9():792335. PubMed ID: 35096822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment.
    Liu L; Jing H; Wu X; Xiang M; Novakovic VA; Wang S; Shi J
    Front Cardiovasc Med; 2022; 9():957006. PubMed ID: 35990983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors.
    Xiang M; Wu X; Jing H; Liu L; Wang C; Wang Y; Novakovic VA; Shi J
    Front Immunol; 2022; 13():955654. PubMed ID: 36248790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-induced procoagulant platelets in severe COVID-19 infection.
    Althaus K; Marini I; Zlamal J; Pelzl L; Singh A; Häberle H; Mehrländer M; Hammer S; Schulze H; Bitzer M; Malek N; Rath D; Bösmüller H; Nieswandt B; Gawaz M; Bakchoul T; Rosenberger P
    Blood; 2021 Feb; 137(8):1061-1071. PubMed ID: 33512415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium dysfunction and thrombosis in COVID-19 with type 2 diabetes.
    Li M; Wu X; Shi J; Niu Y
    Endocrine; 2023 Oct; 82(1):15-27. PubMed ID: 37392341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombotic Phenotype in COVID-19: Focus on Platelets.
    Barale C; Melchionda E; Morotti A; Russo I
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 coagulopathy - what should we treat?
    Chowdary P
    Exp Physiol; 2022 Jul; 107(7):749-758. PubMed ID: 35733235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence.
    Ragnoli B; Da Re B; Galantino A; Kette S; Salotti A; Malerba M
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?
    Ghasemzadeh M; Ahmadi J; Hosseini E
    Thromb Res; 2022 May; 213():179-194. PubMed ID: 35397313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    Ostrowski SR; Søgaard OS; Tolstrup M; Stærke NB; Lundgren J; Østergaard L; Hvas AM
    Front Immunol; 2021; 12():779453. PubMed ID: 34887867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two to tango: endothelial cell TMEM16 scramblases drive coagulation and thrombosis.
    Filep JG
    J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37259922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytopenia and thrombosis in hospitalized patients with COVID-19.
    Mei H; Luo L; Hu Y
    J Hematol Oncol; 2020 Dec; 13(1):161. PubMed ID: 33261634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide induces procoagulant activity through phosphatidylserine exposure and microparticle generation in endothelial cells.
    Zhou J; Li H; Fu Y; Shi J; Hou J; Zhang Y; Liu X; Song P
    Thromb Res; 2011 May; 127(5):466-72. PubMed ID: 21272920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review.
    Cryer MJ; Farhan S; Kaufmann CC; Jäger B; Garg A; Krishnan P; Mehran R; Huber K
    Clin Appl Thromb Hemost; 2022; 28():10760296221074353. PubMed ID: 35068227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunothrombosis and the molecular control of tissue factor by pyroptosis: prospects for new anticoagulants.
    Ryan TAJ; Preston RJS; O'Neill LAJ
    Biochem J; 2022 Mar; 479(6):731-750. PubMed ID: 35344028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.